Odor identification screening improves diagnostic classification in incipient Alzheimer’s disease

Manuscript Number: 

16-0842R1

Author(s): 
Steven E. Arnold, Sushila Kabadi, Dawn Mechanic-Hamilton, Paul J. Moberg, Megan Quarmley, David R. Roalf, David Wolk

Disclosures

Steven E. Arnold

  • Consulting Fees:
    Cowen & Co - on a panel to discuss Alzheimer's disease drugs; Unrelated to manuscrupt

Sushila Kabadi

  • Nothing to Disclose

Dawn Mechanic-Hamilton

  • Consulting Fees:
    <$1000 in consulting fees in 2016 from Neuronix Ltd.
    Grants
    • Agency: 
      Merck and Co. Inc.
      Dates: 
      7/1/15 - present
    • Agency: 
      Claret Medical Inc.
      Dates: 
      1/1/15 - 6/30/15

Paul J. Moberg

  • Nothing to Disclose

Megan Quarmley

  • Nothing to Disclose

David R. Roalf

  • Nothing to Disclose

David Wolk

  • Consulting Fees:
    Upcoming consultation with Merck